1 row is stored for this page
| Field | Field type | Value |
|---|
| generic | String | Ramipril |
| brand | String | Altace |
| structure | File | |
| classes | List of String, delimiter: , | [[:Category:ACE_inhibitors|ACE inhibitor]] • [[:Category:Antihypertensives|Antihypertensive]] |
| mechanism | String | |
| uses | String | '"`UNIQ--vote-00000C2E-QINU`"', '"`UNIQ--vote-00000C2F-QINU`"', '"`UNIQ--vote-00000C30-QINU`"', '"`UNIQ--vote-00000C31-QINU`"' |
| starting_dose | String | 2.5 mg PO once daily (1.25 mg in CHF or volume depletion); titrate to 5-10 mg/d |
| preparations | String | 1.25, 2.5, 5, 10 mg capsules |
| fda_max | String | 20 mg/d (hypertension); 10 mg/d (other indications typical) |
| pill_id | Text | |
| routes | List of String, delimiter: , | Oral |
| onset | String | BP effect 1-2 hours; max at 6 hours |
| duration | String | 24 hours |
| halflife | String | ~13-17 hours (ramiprilat, the active metabolite)'"`UNIQ--ref-00000C32-QINU`"' |
| bioavailability | String | ~28% (oral; food slows but does not reduce absorption)'"`UNIQ--ref-00000C33-QINU`"' |
| pregnancy | String | '''Contraindicated in pregnancy''' (all trimesters); fetal renal injury, oligohydramnios, skull hypoplasia, hypotension'"`UNIQ--ref-00000C34-QINU`"' |
| legal | String | [[USLegal:Prescription only|Rx-only]] in US |
